UB Paderborn / Katalog / Suche / in CDI

1 – 16 von 16

Sortiert nach

Second-Line Oxaliplatin, Folinic Acid, and Fluorouracil Versus Folinic Acid and Fluorouracil Alone for Gemcitabine-Refractory Pancreatic Cancer: Outcomes From the CONKO-003 Trial

Journal of clinical oncology, 2014-08, Vol.32 (23), p.2423-2429

2014

Link zum Volltext

Verfügbarkeit prüfen

Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: A phase III-study from the German CONKO-study group

European journal of cancer (1990), 2011-07, Vol.47 (11), p.1676-1681

2011

Link zum Volltext

Verfügbarkeit prüfen

Baseline and On-Treatment Markers Determining Prognosis of First-Line Chemotherapy in Combination with Bevacizumab in Patients with Metastatic Colorectal Cancer

Oncology research and treatment, 2017, Vol.40 (1-2), p.21-26

2017

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab plus chemotherapy as first-line treatment for patients with metastatic colorectal cancer: Results from a large German community-based observational cohort study

Acta oncologica, 2015-02, Vol.54 (2), p.171-178

2015

Link zum Volltext

Verfügbarkeit prüfen

Intravenous and Oral ibandronate are equally effective in metastatic bone pain reduction regardless of previous bisphosphonate treatment

Bone (New York, N.Y.), 2008-03, Vol.42, p.S97-S98

2008

Link zum Volltext

Verfügbarkeit prüfen

Rapid Selection of Sotrovimab Escape Variants in Severe Acute Respiratory Syndrome Coronavirus 2 Omicron-Infected Immunocompromised Patients

Clinical infectious diseases, 2023-02, Vol.76 (3), p.408-415

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical presentation and diagnosis of adult patients with non‐Hodgkin lymphoma in Sub‐Saharan Africa

British journal of haematology, 2020-07, Vol.190 (2), p.209-221

2020

Link zum Volltext

Verfügbarkeit prüfen

Alkyl C and hydrophobicity in B and C horizons of an acid forest soil

Journal of plant nutrition and soil science, 2004-12, Vol.167 (6), p.685-692

2004

Link zum Volltext

Verfügbarkeit prüfen

Interaction Analysis

Proteomics Sample Preparation, 2008, p.295-315

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(15)
Buchkapitel
(1)

Sprache

Englisch
(16)
Japanisch
(4)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Second-Line Oxaliplatin, Folinic Acid, and Fluorouracil Versus Folinic Acid and Fluorouracil Alone for Gemcitabine-Refractory Pancreatic Cancer: Outcomes From the CONKO-003 Trial

Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: A phase III-study from the German CONKO-study group

CD34+ FISH As a New Method for Molecular-Cytogenetic Diagnostic From Peripheral Blood in MDS: Update of the Multicenter German Prospective Diagnostic Study

Molecular cytogenetic monitoring from CD34+ peripheral blood cells in myelodysplastic syndromes: First results from a prospective multicenter German diagnostic study

Phase III randomized, double‐blind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum‐containing regimen (RADPAC)

Baseline and On-Treatment Markers Determining Prognosis of First-Line Chemotherapy in Combination with Bevacizumab in Patients with Metastatic Colorectal Cancer

A randomized, double-blind, multi-center phase III study evaluating paclitaxel with and without RAD001 in patients with gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum-containing regimen (RADPAC)

A randomized, double-blind, multicenter phase III study evaluating paclitaxel with and without RAD001 in patients with gastric cancer who have progressed after therapy with a fluoropyrimidine/platinum-containing regimen (RADPAC)

Bevacizumab plus chemotherapy as first-line treatment for patients with metastatic colorectal cancer: Results from a large German community-based observational cohort study

Intravenous and Oral ibandronate are equally effective in metastatic bone pain reduction regardless of previous bisphosphonate treatment

Rapid Selection of Sotrovimab Escape Variants in Severe Acute Respiratory Syndrome Coronavirus 2 Omicron-Infected Immunocompromised Patients

Clinical presentation and diagnosis of adult patients with non‐Hodgkin lymphoma in Sub‐Saharan Africa

Functional organization of the yeast proteome by systematic analysis of protein complexes

Guideline Concordance of Treatment and Outcomes Among Adult Non-Hodgkin Lymphoma Patients in Sub-Saharan Africa: A Multinational, Population-Based Cohort

Alkyl C and hydrophobicity in B and C horizons of an acid forest soil

Interaction Analysis

Suchergebnisse filtern